AxoGen, Inc. (AXGN) CEO Karen L. Zaderej Buys 10,000 Shares of Stock
AxoGen, Inc. (NASDAQ:AXGN) CEO Karen L. Zaderej purchased 10,000 shares of the firm’s stock in a transaction dated Friday, October 7th. The stock was purchased at an average cost of $7.50 per share, with a total value of $75,000.00. Following the acquisition, the chief executive officer now directly owns 242,147 shares in the company, valued at $1,816,102.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of AxoGen, Inc. (NASDAQ:AXGN) opened at 8.72 on Monday. AxoGen, Inc. has a 52-week low of $4.08 and a 52-week high of $9.88. The company’s market capitalization is $262.75 million. The company has a 50-day moving average of $8.74 and a 200 day moving average of $6.99.
AxoGen (NASDAQ:AXGN) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.09) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.12) by $0.03. AxoGen had a negative net margin of 37.90% and a negative return on equity of 193.60%. Analysts predict that AxoGen, Inc. will post ($0.40) earnings per share for the current year.
Separately, Wedbush reaffirmed an “outperform” rating and issued a $10.00 price objective (up from $9.00) on shares of AxoGen in a research report on Thursday, August 4th.
Several institutional investors have recently added to or reduced their stakes in AXGN. Nationwide Fund Advisors acquired a new position in AxoGen during the second quarter valued at about $105,000. TFS Capital LLC acquired a new position in AxoGen during the second quarter valued at about $113,000. Rhumbline Advisers acquired a new position in AxoGen during the second quarter valued at about $132,000. Menta Capital LLC acquired a new position in AxoGen during the second quarter valued at about $183,000. Finally, KCG Holdings Inc. acquired a new position in AxoGen during the second quarter valued at about $200,000. 57.87% of the stock is owned by hedge funds and other institutional investors.
Receive News & Stock Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related stocks with our FREE daily email newsletter.